Nature Communications (Dec 2016)

A TLR9 agonist promotes IL-22-dependent pancreatic islet allograft survival in type 1 diabetic mice

  • Deepak Tripathi,
  • Sambasivan Venkatasubramanian,
  • Satyanarayana S. Cheekatla,
  • Padmaja Paidipally,
  • Elwyn Welch,
  • Amy R. Tvinnereim,
  • Ramakrishna Vankayalapati

DOI
https://doi.org/10.1038/ncomms13896
Journal volume & issue
Vol. 7, no. 1
pp. 1 – 14

Abstract

Read online

Tolerance is required to prevent rejection of intrahepatic islet allografts as a potential treatment for type 1 diabetes. Here the authors show that IL-22 produced by NK1.1+cells in the liver of streptozotocin T1D model mice can drive tolerance to allografted islets.